surgery
Conditions
Interventions
Experimental group1:ciprofol 0.6mg/kg/h
Experimental group2:ciprofol 0.8mg/kg/h
Experimental group3:ciprofol 1.0mg/kg/h
Experimental group4:control 5mg/kg/h
Sponsors
Jinghai Hospital of Tianjin
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Non-cardiothoracic and neurosurgery operations within 2 hours of the elective; 2. Aged 20 to 65 years; 3. ASA classification I/II; 4. Agree to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Previous neurological diseases such as schizophrenia, epilepsy, and Parkinson's; 2. Brain injury or neurosurgery, cardiothoracic surgery; 3. Recently taking analgesic, sedative, anti-anxiety, anti-psychotic and other drugs; 4. Critical illness, acute and severe hypertension, severe diabetes, liver and kidney insufficiency, severe heart disease; 5. The researcher or the attending doctor believes that there are reasons for not participating in this study; 6. Participating in other clinical studies at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vital signs during sedation; | — |
Countries
China
Contacts
Public ContactZhang Shidong
Jinghai Hospital of Tianjin
Outcome results
None listed